Am J Transplant, Volume 3, Suppl 5 Archives - Page 130 of 178 - ATC Abstracts

2013 American Transplant Congress
Correlation of Zero-Time Biopsies in Deceased Renal Transplantation and One Year Graft Function
A. Matos, N. Camara, L. Requiao-Moura, E. Tonato, M. Souza Durao, E. Ferraz, M. Fregonesi Silva, M. Borreli, D. Malheiros, A. Pacheco-Silva
Transplantation, Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Immunology, Universidade de Sao Paulo, Sao Paulo, Brazil; Pathology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
Zero-time biopsy provide important information about the organ quality; however its role as acute or chronic renal function predictor is not established. Materials and Methods:…
2013 American Transplant Congress
Angiopoietin2: A Prognostic Marker in Kidney Transplantation
W. Westendorp, L. Koudstaal, J. Damman, J. Burgerhof, M. Seelen, H. van Goor, R. Ploeg, H. Leuvenink
Surgery, University Medical Center Groningen, Groningen, Netherlands; Pathology, University Medical Center Groningen, Groningen, Netherlands; Epidemiology, University Medical Center Groningen, Groningen, Netherlands; Nephrology, University Medical Center Groningen, Groningen, Netherlands; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom
Organs derived from deceased brain dead (DBD) donors show worse organ function and more acute rejection episodes than organs derived from living donors. Human studies…
2013 American Transplant Congress
Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid-Organ Transplant Recipients
O. Manuel, G. Kralidis, N. Mueller, H. Hirsch, C. Garzoni, C. Van Delden, C. Berger, K. Boggian, A. Cusini, M. Koller, M. Weisser, M. Pascual, P. Meylan, the STCS
CHUV, Lausanne; , Basel; , Zurich; , Bern; , Geneva; , St Gallen, Switzerland
Background: Antiviral prophylaxis and preemptive therapy are currently used for preventing cytomegalovirus (CMV) disease in solid-organ transplant (SOT) recipients. However, both approaches have not been…
2013 American Transplant Congress
Effect of Ciprofloxacin Prophylaxis on BK Virus Infection after Renal Transplantation
D. Min, D. Vu, B. Kawewat, J. Poulsen, R. Naraghi, I. Hutchinson, T. Shah
Western Unveristy of Health Sciences, Pomona, CA; St. Vincent Medical Center, Los Angeles, CA; National Institute of Transplantation, Los Angeles, CA; Transplant Research Institute, Los Angeles, CA; University of Southern California, Los Angeles, CA
Background: BK virus nephropathy (BKVN) is a common viral infection that affects up to 10% of renal transplant recipients (RTRs), causing allograft dysfunction and graft…
2013 American Transplant Congress
Anti-CD20 Antibody Therapy for Antibody-Mediated Rejection of Renal Allografts in a Mouse Model
T. Abe, D. Ishii, R. Fan, C. Su, S. Iida, W. Baldwin III, N. Nonomura, S. Takahara, R. Fairchild
Immunology, Cleveland Clinic, Cleveland, OH; Osaka University, Suita, Japan
INTRODUCTION: We have reported murine recipients lacking the chemokine receptor CCR5 reject renal allografts with marked C4d deposition in peritubular capillaries and high serum donor-reactive…
2013 American Transplant Congress
Outcomes of Simultaneous Liver-Kidney Transplantation (SLK) from Donation after Cardiac Death (DCD) Donors and from Donation after Brain Death Donors (DBD)
H. Wadei, I. Bulatao, T. Gonwa, A. Keaveny, M. Mai, B. Taner
Transplantation, Mayo Clinic, Jacksonville, FL
Data concerning outcomes of SLK tx from DCD donors is lacking. Methods: Patient and graft survivals were compared between 12 DCD-SLK and 54 DBD-SLK performed…
2013 American Transplant Congress
Role of Immunosuppression on Hyperuricemia and Proteinuria Affecting Graft Survival, The
U. Cakir, I. Berber, E. Gurluler, N. Gures, A. Alim, A. Gurkan
Transplant Center, Acibadem University, Istanbul, Turkey
The negative impact of serum uric acid (UA) on the function of transplanted kidneys is still being investigated. We aimed to evaluate the predictive value…
2013 American Transplant Congress
Successful Tolerance Induction of Cardiac Allografts in Nonhuman Primates through Donor Kidney Co-Transplantation
M. Tonsho, G. Benichou, S. Boskovic, O. Nadazdin, N. Smith, R. Colvin, D. Sachs, A. Cosimi, T. Kawai, J. Madsen
Transplant Surgery, Massachusetts General Hospital, Boston, MA; Pathology, Massachusetts General Hospital, Boston, MA; Transplant Biology Research Center, Massachusetts General Hospital, Boston, MA
BackgroundTolerance of allogeneic kidney transplants has been achieved in NHP and human recipients using a mixed chimerism approach. However, the same approach has failed to…
2013 American Transplant Congress
Association of Interferon-γ Gene Polymorphisms with Cytomegalovirus Viremia in Renal Allograft Recipients
D. Vu, P. Sakharkar, T. Shah, Y. Qazi, R. Naraghi, J. Poulsen, I. Hutchinson, D. Min
National Institute of Transplantation, Los Angeles, CA; St. Vincent Medical Center, Los Angeles, CA; Western University of Health Sciences, Pomona, CA; Roosevelt University College of Pharmacy, Schaumburg, IL; University of Southern California, Los Angeles, CA; Transplant Research Institute, Los Angeles, CA
Background: Cytomegalovirus (CMV) is the most common cause of viral infection, causing morbidity and mortality among kidney transplant recipients (RTRs). Cytokines such as tumor necrosis…
2013 American Transplant Congress
Impact of Donor Kidney Disease on Outcomes Following Deceased Donor Kidney Transplantation
V. Kosmoliaptsis, M. Salji, V. Bardsley, M. Finlay, H. Copley, M. Griffiths, J. Bradley, G. Pettigrew
Department of Surgery, University of Cambridge, Cambridge, United Kingdom; Department of Pathology, University of Cambridge, Cambridge, United Kingdom
Background: Increasing numbers of Donation after Circulatory Death (DCD) kidneys are retrieved from Expanded Criteria (EC) donors, but uncertainties persist regarding how best to assess…